NCT05795907View on ClinicalTrials.gov

Single & Multiple Ascending Dose Study of SAR443820 in Healthy Adult Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

November 30, 2020

Primary Completion Date

July 20, 2021

Study Completion Date

July 20, 2021

Conditions
Amyotrophic Lateral Sclerosis (Healthy Volunteers)
Interventions
DRUG

SAR443820

Capsule / Oral

DRUG

Placebo

Matching Capsule / Oral

Trial Locations (1)

55144

Prism Research-Site Number:8400001, Saint Paul

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT05795907 - Single & Multiple Ascending Dose Study of SAR443820 in Healthy Adult Participants | Biotech Hunter | Biotech Hunter